Form D — Alphina Therapeutics, Inc.
0001882991-26-000003 · filed 2026-03-16
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $10,000,000
- Total sold
- $153,715
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Alphina Therapeutics, Inc.
- CIK
- 1882991
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 55 Church Street
New Haven, CT 06510 - Phone
- (650) 438-8738
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Nicholas J Galli · Executive OfficerNew Haven, CT Find on LinkedIn ↗
-
Ranjit Bindra · DirectorNew Haven, CT Find on LinkedIn ↗
-
Kevin Rakin · DirectorNew Haven, CT Find on LinkedIn ↗
-
Colleen Cuffaro · DirectorWestport, CT Find on LinkedIn ↗
-
Barbara Fox · Executive OfficerNew Haven, CT Find on LinkedIn ↗
-
Matthew Cohen · DirectorBala Cynwyd, PA Find on LinkedIn ↗
View original on SEC EDGAR.